Corporations Just Big Tests Flashcards
Derivative Lawsuit test
Need
- STANDING
- DEMAND (unless DE, “universal non-demand”)
- Underlying claim of corporation
- Director or officer failed to sue on corporate claim
Assert claim on behalf of corporation with recovery going to corporation
§ 10(b)/Rule 10b-5 Elements (Insider Trading)
§ 10(b)/Rule 10b-5 Elements
- Material misstatement or omission
a. Misappropriation Theory
b. Equal access rule - In connection with the purchase or sale of a security (“standing”)
- Made with intent to deceive (“scienter”) (recklessness enough)
- Upon which there is reliance ← “fraud on the market” doctrine.
- Causing
- Injury (e.g., damages)
10b-5 Elements: Material Misstatement
Material: “substantial likelihood reasonable investor would consider it important”
If it’s a misstatement, quick analysis you got a fraud claim
If it’s an omission, need a bigger analysis for fraud or insider trading –> go to Misappropriation Theory or Equal Access Rule
Derivative Lawsuit: Standing element
- Shareholder was shareholder of the corporation at the time of the act or omission
- Will be a shareholder for duration of action
- Will “fairly and adequately” represent the interests of the shareholders
- Took specific action to gain satisfaction from the board or if not, why they did not take this action
Derivative Lawsuit: Demand element
Demand is met if:
- There is actual demand OR
- Shareholders can argue that demand would be futile.
Derivative Lawsuit: if arguing futility of demand
Court must determine whether
- the complaint casts doubt on the presumption that the directors acted
(i) independently and
(ii) free from conflicts (majority of the board was interested or lacked independence or breach of duty to exercise due care)
IF NOT:
- Whether complaint pleads sufficient facts to overcome BJR
10b-5 Elements: Standing
Simple rule: need to be actual purchaser or seller of securities at time of omission or misrepresentation.
OWNING STOCK NOT ENOUGH! (Blue Chip Stamps v. Manor Drug (US 1975))
Tipper/Tippee Liability
Original Tipper:
- Was there a violation of Fiduciary duty?
- Did he receive a personal benefit? (Financial benefit is the best bet)
Tippee:
3. Knows or should have known of breach? (missapropriation)
10b-5 Elements: Scienter
“Mental state embracing intent to deceive, manipulate, defraud” (Ernst & Ernst v. Hochfelder (US 1976))
Most courts treat “recklessness” as enough to constitute scienter for purposes of § 10(b)/Rule 10b-5
Typically, strong inference arises upon showing of possession of information
10b-5 Elements: Reliance “fraud on the market”
Misleading statements distort stock price, even if purchasers don’t directly rely on misstatements. This meets this prong.
BUT: Any showing that severs link between misrepresentation and price paid is sufficient to rebut presumption (e.g., privy to information, bought/sold for other reasons)
10b-5 Elements: Causation
Seems to require that plaintiffs demonstrate price movements caused by fraud, as opposed to other factors
Note: Very high burden on the plaintiff
10b-5 Elements: Injury
Remedy:
Compensation?
Deterrence?
BJR
Prohibits courts from interfering in business decisions made by the directors in
- Not gross negligence
- in the absence of a conflict of interest.
Duty of Care
Directors and officers must:
- Act in good faith and
- In a manner a director may reasonably believe to be in the best interest of the corporation
Actions hurt corporation? Duty of care time
Duty of Loyalty
- No self-dealing (even if no injury to corp)
2. Must act without personal economic conflict. (ie. family member has interest in transaction)
Safe harbor
Interested director can shield themselves from self-dealing by showing
- Disclosed material information, and then:
- fairness, or
- Approval of disinterested directors or shareholders
Material
Substantial likelihood that a reasonable investor would consider it important in making a business decision.
Direct Shareholder Suit
Plaintiff’s claimed direct injury must be independent of any alleged injury to the corporation
Breach of fiduciary duty owed to a particular shareholder by an officer or director is a proper subject for shareholder’s direct action against that officer.
Failure to Monitor
Shareholders must show:
- Directors should have known about the activity
- Directors took no steps to address the activity
- Failure to address the activity caused losses to the company
Directors knew they were not discharging fiduciary duties
Adopting a fundamental corporate change
- Majority of the board of directors adopts a resolution reccommending change
- Notice of the change is sent to all shareholders for voting (not less than 10 or more than 60 days before meeting)
- Change approved by shareholders
- Formalized in the articles
Section 16(b)
enforced by issuer itself or someone suing on behalf of issuer (derivative suit)
Surrender to the corporation of any profit:
- realized by any director, officer, or a shareholder owning more than 10% of a class of the corporations stock
- from the purchase and sale, or sale and purchase of any equity security
- within a six-month period is required.
No proof of insider information is required.
Misappropriation Theory (10b - materiality)
Fraud committed “in connection with” securities transaction when one:
- misappropriates confidential information for trading securities,
- in breach of duty owed to source of information
Breach of “trust and duty” (not really expanded elsewhere)
Equal Access Theory (10b - materiality)
Anyone in possession of material non-public information is liable if they did not
- disclose the information or
- abstain from trading the securities while the information remains disclosed.
16(a)
Directors, officers, shareholders with 10% shares:
- Must disclose when they achieve insider status
- Any subsequent trades
- By the end of the second business day following the transaction